Changbing Wang

2.9k total citations
66 papers, 2.3k citations indexed

About

Changbing Wang is a scholar working on Epidemiology, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, Changbing Wang has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Nutrition and Dietetics and 17 papers in Molecular Biology. Recurrent topics in Changbing Wang's work include Selenium in Biological Systems (17 papers), Viral gastroenteritis research and epidemiology (11 papers) and RNA Interference and Gene Delivery (10 papers). Changbing Wang is often cited by papers focused on Selenium in Biological Systems (17 papers), Viral gastroenteritis research and epidemiology (11 papers) and RNA Interference and Gene Delivery (10 papers). Changbing Wang collaborates with scholars based in China, United States and Cuba. Changbing Wang's co-authors include Mingqi Zhao, Yinghua Li, Tiantian Xu, Zhengfang Lin, Bing Zhu, Yu Xia, Min Guo, Bing Zhu, Liang Hua and Misi Xiao and has published in prestigious journals such as PLoS ONE, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Changbing Wang

65 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changbing Wang China 30 592 586 489 477 372 66 2.3k
Yinghua Li China 33 854 1.4× 889 1.5× 619 1.3× 607 1.3× 437 1.2× 111 3.0k
Tiantian Xu China 28 659 1.1× 510 0.9× 427 0.9× 378 0.8× 257 0.7× 114 2.4k
Min Guo China 28 485 0.8× 543 0.9× 388 0.8× 283 0.6× 211 0.6× 69 1.9k
Zhengfang Lin China 21 410 0.7× 424 0.7× 340 0.7× 359 0.8× 279 0.8× 36 1.5k
Xuesong Sun China 27 863 1.5× 281 0.5× 183 0.4× 306 0.6× 165 0.4× 119 2.4k
Yu Xia China 29 529 0.9× 557 1.0× 445 0.9× 716 1.5× 174 0.5× 107 2.3k
Lingli Chen China 30 1.2k 2.0× 213 0.4× 519 1.1× 174 0.4× 218 0.6× 89 2.8k
Johan Karlsson Sweden 29 1.6k 2.6× 218 0.4× 846 1.7× 300 0.6× 206 0.6× 50 4.6k
Somenath Roy India 34 773 1.3× 140 0.2× 632 1.3× 981 2.1× 255 0.7× 105 3.4k
Min Chen China 26 1.0k 1.7× 169 0.3× 265 0.5× 234 0.5× 266 0.7× 161 2.8k

Countries citing papers authored by Changbing Wang

Since Specialization
Citations

This map shows the geographic impact of Changbing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changbing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changbing Wang more than expected).

Fields of papers citing papers by Changbing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changbing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changbing Wang. The network helps show where Changbing Wang may publish in the future.

Co-authorship network of co-authors of Changbing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changbing Wang. A scholar is included among the top collaborators of Changbing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changbing Wang. Changbing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Min, Jian‐Piao Cai, Wei Wei, et al.. (2024). PEG-SeNPs as therapeutic agents inhibiting apoptosis and inflammation of cells infected with H1N1 influenza A virus. Scientific Reports. 14(1). 21318–21318. 2 indexed citations
2.
Wang, Changbing, Yujie Yang, Kaixuan Wu, et al.. (2024). An Outbreak of Human Adenovirus Infection Among Children Post COVID‐19 Pandemic in Southern China. Journal of Medical Virology. 96(12). e70139–e70139. 3 indexed citations
5.
Lin, Tao, Changbing Wang, Wanli Liang, et al.. (2022). Human adenovirus (HAdV) infection in children with acute respiratory tract infections in Guangzhou, China, 2010–2021: a molecular epidemiology study. World Journal of Pediatrics. 18(8). 545–552. 27 indexed citations
6.
Wang, Changbing, Yu Xia, Shaochuan Huo, et al.. (2020). <p>Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy</p>. International Journal of Nanomedicine. Volume 15. 9759–9770. 28 indexed citations
7.
Wang, Changbing, et al.. (2020). Outcome of bone–patellar tendon–bone vs hamstring tendon autograft for anterior cruciate ligament reconstruction. Medicine. 99(48). e23476–e23476. 40 indexed citations
8.
Xia, Yu, Misi Xiao, Mingqi Zhao, et al.. (2019). Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. Materials Science and Engineering C. 106. 110100–110100. 76 indexed citations
9.
Xia, Yu, Changbing Wang, Tiantian Xu, et al.. (2018). Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy. RSC Advances. 8(4). 1917–1926. 17 indexed citations
10.
Xia, Yu, Mingqi Zhao, Yi Chen, et al.. (2018). Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy. RSC Advances. 8(46). 25932–25940. 34 indexed citations
11.
Xia, Yu, Yi Chen, Liang Hua, et al.. (2018). Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy. International Journal of Nanomedicine. Volume 13. 6929–6939. 53 indexed citations
12.
Xia, Yu, Min Guo, Tiantian Xu, et al.. (2018). siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy. International Journal of Nanomedicine. Volume 13. 1539–1552. 65 indexed citations
13.
Lin, Zhengfang, Yinghua Li, Yu Xia, et al.. (2018). Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway. International Journal of Nanomedicine. Volume 13. 5787–5797. 72 indexed citations
14.
Xia, Yu, Tiantian Xu, Changbing Wang, et al.. (2017). Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy. International Journal of Nanomedicine. Volume 13. 143–159. 64 indexed citations
15.
Xia, Yu, Zhengfang Lin, Yinghua Li, et al.. (2017). Targeted delivery of siRNA using RGDfC-conjugated functionalized selenium nanoparticles for anticancer therapy. Journal of Materials Chemistry B. 5(33). 6941–6952. 42 indexed citations
16.
Wang, Shutao, Changbing Wang, Pan Zhao, et al.. (2017). Applications of optical technology in gas concentration detection. Guangdian gongcheng. 44(9). 862–871.
17.
Zhu, Bing, Tiantian Xu, Zhengfang Lin, et al.. (2017). Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection. Archives of Virology. 162(6). 1649–1660. 8 indexed citations
18.
Li, Yinghua, Zhengfang Lin, Min Guo, et al.. (2017). Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. International Journal of Nanomedicine. Volume 12. 5733–5743. 122 indexed citations
19.
Chen, Yi, Fanghua Liu, Changbing Wang, et al.. (2016). Molecular Identification and Epidemiological Features of Human Adenoviruses Associated with Acute Respiratory Infections in Hospitalized Children in Southern China, 2012-2013. PLoS ONE. 11(5). e0155412–e0155412. 57 indexed citations
20.
Wang, Changbing, Xingui Tian, Mingqi Zhao, et al.. (2013). Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus. Virus Research. 176(1-2). 33–36. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026